PPIAL4 inhibitors are a class of chemical compounds that interact with the PPIAL4 protein, which is a member of the peptidyl-prolyl cis-trans isomerase family. These enzymes, known as cyclophilins, play a crucial role in the folding of proteins by catalyzing the cis-trans isomerization of peptide bonds at proline residues. The PPIAL4 protein itself is less studied compared to other members of the cyclophilin family, but it is believed to participate in key processes of cellular homeostasis, particularly related to protein folding and the maintenance of proper cellular structure. The inhibition of PPIAL4 interferes with its ability to catalyze these specific conformational changes in proteins, which could affect multiple pathways related to protein stability and interaction dynamics within cells.
Chemically, PPIAL4 inhibitors are designed to bind selectively to the active sites or allosteric regions of the PPIAL4 enzyme, blocking its catalytic function. These inhibitors typically interact with the enzyme by mimicking the transition state of the peptide bond during isomerization, thereby stabilizing the enzyme in a non-functional conformation. Their design often involves understanding the structural nuances of the PPIAL4 protein, such as its binding pockets and surface charge distribution, which guide the creation of molecules with high affinity and selectivity. As a result, these inhibitors are crucial tools in studying the role of PPIAL4 in various biochemical pathways, allowing researchers to explore its physiological relevance and interactions within complex cellular environments. The development and study of PPIAL4 inhibitors contribute to a deeper understanding of how peptidyl-prolyl isomerases regulate protein folding and contribute to the broader landscape of molecular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Cyclosporin A binds to the cyclophilin family of proteins and inhibits their peptidylprolyl isomerase activity, directly inhibiting peptidylprolyl isomerase A like 4A's functional activity. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $76.00 $148.00 | 9 | |
FK-506 binds to FKBP12, a member of the FK-binding protein family, which shares peptidyl-prolyl isomerase activity with peptidylprolyl isomerase A like 4A, leading to the inhibition of the isomerase activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin forms a complex with FKBP12, and this complex does not inhibit mTOR but can inhibit the PPIase activity of FKBP proteins, thereby inhibiting peptidylprolyl isomerase A like 4A by competition. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
Although primarily known as a PPAR-gamma agonist, Pioglitazone has been observed to bind and inhibit cyclophilins, hence could inhibit peptidylprolyl isomerase A like 4A's isomerase activity. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $275.00 $928.00 $1543.00 | 14 | |
E-64 is an irreversible cysteine protease inhibitor that can bind to thiol groups of cysteine residues; as peptidylprolyl isomerase A like 4A has a catalytic cysteine, its activity could be inhibited by E-64. | ||||||
L-685,458 | 292632-98-5 | sc-204042 sc-204042A | 1 mg 5 mg | $337.00 $1000.00 | 4 | |
L-685,458 is an aspartyl protease inhibitor that, while specific to γ-secretase, could hypothetically inhibit peptidylprolyl isomerase A like 4A, as the protein may have aspartyl residues critical for its isomerase activity. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $46.00 $140.00 $680.00 | 16 | |
PD173074 is a selective FGFR tyrosine kinase inhibitor, but if peptidylprolyl isomerase A like 4A were phosphorylated as a regulatory mechanism, this inhibitor could reduce its activity. | ||||||